Evolving Indications, Challenges and Advances in Cardiac Resynchronization Therapy for Heart Failure
Temidayo A Abe1, Endurance O Evbayekha2, Larry R Jackson3
1Division of Cardiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Journal of Cardiac Failure
|April 18, 2025
Summary
Cardiac resynchronization therapy (CRT) improves heart failure but some patients lack benefit. Novel conduction system pacing shows promise as a more physiological alternative to biventricular pacing.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Cardiac resynchronization therapy (CRT) using biventricular pacing has improved heart failure outcomes for two decades.
- However, a significant portion of patients do not respond to CRT, highlighting limitations in patient selection and therapy optimization.
Purpose of the Study:
- To review the challenges and advancements in CRT, including patient selection, programming, and efficacy assessment.
- To explore alternative pacing strategies, specifically conduction system pacing, as a potentially more physiological approach.
Main Methods:
- Review of existing literature on CRT efficacy, patient selection criteria, and procedural challenges.
- Analysis of emerging techniques in electrocardiography and imaging for improved patient stratification.
- Evaluation of preliminary data on conduction system pacing compared to traditional biventricular pacing.
Main Results:
- Suboptimal patient selection, characterizing conduction disease, procedural issues, and programming limitations hinder CRT success.
- Existing guidelines lack consensus on CRT efficacy evaluation, contributing to underuse in certain demographics.
- Conduction system pacing demonstrates comparable or superior efficacy in early studies, suggesting a more physiological alternative.
Conclusions:
- Despite CRT's benefits, non-response remains a challenge, necessitating improved patient selection and therapeutic strategies.
- Conduction system pacing represents a promising advancement, potentially offering a more effective and physiological approach to CRT.
- Further research is crucial to validate conduction system pacing and refine CRT protocols for broader patient benefit.
Related Concept Videos
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
Heart Failure Drugs: Inotropic Agents
405
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
405
Pulse rhythm
717
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
717
Heart Failure Drugs: β-Blockers
260
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
260


